Elevated concentrations of α-defensins in gastric juice of patients with Helicobacter pylori infection

American Journal of Gastroenterology

Volumn 99, Issue 10, 2004, Pages 1916-1923

  Isomoto, Hajime ^a   Mukae, Hiroshi ^b   Ishimoto, Hiroshi ^b   Date, Yukari ^b   Nishi, Yoshito ^b   Inoue, Kenichiro ^b   Wada, Akihiro ^b   Hirayama, Toshiya ^b   Nakazato, Masamitsu ^b   Kohno, Shigeru ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; DEFENSIN 1; DEFENSIN 2; DEFENSIN 3; INTERLEUKIN 8; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH JUICE; STOMACH MUCOSA;

ADULT; AGED; ALPHA-DEFENSINS; FEMALE; GASTRIC JUICE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED;

EID: 7044231553     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40334.x     Document Type: Article

References (37)

1. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990;161:626-33.
2. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: The immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000;54:615-40.
3. Zevering Y, Jacob L, Meyer TF. Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut 1999;45:465-74.
4. Shimoyama T, Crabtree JE. Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut 1998;43 (Suppl 1):S2-S5.
5. Allen LAH. The role of the neutrophils and phagocytosis in infection caused by Helicobacter pylori. Curr Opin Infect Dis 2001;14:273-7.
6. Isomoto H, Inoue K, Furusu H, et al. High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection. Aliment Pharmacol Ther 2003;18:101-7.
7. van Wetering S, Sterk PJ, Rabe KF, et al. Defensins: Key players or bystanders in infection, injury, and repair in the lung. J Allergy Clin Immunol 1999;104:1131-8.
8. Chertov O, Yang D, Howard OMZ, et al. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000;177:68-78.
9. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000;1:141-50.
10. O'Neil DA, Cole SP, Martin-Porter E, et al. Regulation of human β-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun 2000;68:5412-5.
11. Bajaj-Elliott M, Smith GV, Domizio P, et al. Modulation of host antimicrobial peptide (β-defensins 1 and 2) expression during gastritis. Gut 2002;51:356-61.
12. Uehara N, Yagihashi A, Kondoh K, et al. Human β-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: Antimicrobial effect of overexpression. J Med Microbiol 2003;52:41-5.
13. Hamanaka Y, Nakashima M, Wada A, et al. Expression of human β-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: Antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001;49:481-7.
14. Wehkamp J, Schmidt K, Herrlinger KR, et al. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003;56:352-7.
15. Shiomi K, Nakazato M, Ihi T, et al. Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Commun 1993;195:1336-44.
16. Thomson ABR, Appleman S, Keelan M, et al. Role of gastric mucosal and gastric juice cytokine concentrations in development of biophosphonate damage to gastric mucosa. Dig Dis Sci 2003;48:308-14.
17. 2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori. Helicobacter 2003;8:111-9.
18. Price AB. The Sydney system; histological division. J Gastroenterol Hepatol 1991;6:209-22.
19. Morini S, Zullo A, Hassan C, et al. Gastric cardiac inflammation: Role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol 2001;96:2337-40.
20. Isomoto H, Mizuta Y, Miyazaki M, et al. Implication of NF-κB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 2000;95:2768-76.
21. Isomoto H, Miyazaki M, Mizuta Y, et al. Expression of nuclear factor κB in Helicobacter pylori-infected gastric mucosa detected with Southwestern histochemistry. Scand J Gastroenterol 2000;35:247-54.
22. Isomoto H, Furusu H, Morikawa T, et al. 5-day and 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter infection. Aliment Pharmacol Ther 2000;14:1619-23.
23. Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003;98:551-6.
24. Hiratsuka T, Nakazato M, Date Y, et al. identification of human b-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998;249:943-7.
25. Nakazato M, Shiomi K, Date Y, et al. Isolation and sequence determinants of 6- and 8-kDa precursors of human neutrophil peptides from bone marrow, plasma and peripheral blood neutrophils. Biochem Biophys Res Commun 1995;211:1053-62.
26. Date Y, Nakazato M, Shiomi K, et al. Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. Ann Hematol 1994;69:73-7.
27. Mukae H, Iiboshi H, Nakazato M, et al. Raised plasma concentrations of α-defensins in patients with idiopathic pulmonary fibrosis. Thorax 2002;57:623-8.
28. Ashitani J, Mukae H, Hiratsuka T, et al. Elevated levels of α-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 2002;121:519-26.
29. Ihi T, Nakazato M, Mukae H, et al. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis 1997;25:1134-40.
30. Ashitani J, Mukae H, Nakazato M, et al. Elevated pleural fluid levels of defensins in patients with empyema. Chest 1998;113:788-94.
31. Soong LB, Ganz T, Ellison A, et al. Purification and characterization of defensins from cystic fibrosis sputum. Inflamm Res 1997;46:98-102.
32. Ashitani J, Mukae H, Nakazato M, et al. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis. Eur Respir J 1998;11:104-11.
33. Okrent DG, Lichtenstein AK, Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis 1990;141:179-85.
34. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995;17:103-8.
35. Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998;9:9-23.
36. + Helicobacter pylori strains. Lab Invest 1995;71:760-70.
37. van Wetering S, Mannesse-Lazeroms SPG, van Sterkenburg MJA, et al. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol 1997;272:L888-96.